| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/26/2000 | CN1251612A Novel compound |
| 04/26/2000 | CN1251611A USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 04/26/2000 | CN1251610A Novel mouse CXC chemokine receptor |
| 04/26/2000 | CN1251609A Method and product for analyzing polymers |
| 04/26/2000 | CN1251593A Selection of proteins using RNA-protein fusions |
| 04/26/2000 | CN1251390A Human guanosine monophophate reductase and its coding sequence and preparation method |
| 04/26/2000 | CN1251389A Ligand for regulating exogenic expression through molting hormone receptor complex |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/25/2000 | US6054638 Soybean ADP ribosylation factor |
| 04/25/2000 | US6054637 Signal sequences for vacuolar sorting |
| 04/25/2000 | US6054636 Nucleic acid fragment or its complement which codes for chalcone isomerase; for altered expression of enzymes in transformed host cells |
| 04/25/2000 | US6054635 Chimeric gene of a promoter from the e4 gene operably linked to heterologous nucleotide sequence; for moderate-level, constitutive expression |
| 04/25/2000 | US6054633 Live mouse mutagenesis systems for testing mutagenic agents in vivo |
| 04/25/2000 | US6054632 Method of making monoclonal antibodies using polymorphic transgenic animals |
| 04/25/2000 | US6054576 Contacting with mixture of anhydrous alkylamine, trialkylamine and polar organic solvent to remove base and phosphate blocking groups, contacting with anhydrous triethylamine.hydrogen fluoride to remove hydroxyl blockers |
| 04/25/2000 | US6054575 Recombinant or synthetic nucleic acid of a specific nucleotide sequence or its complement; for transcription of another nucleic acid |
| 04/25/2000 | US6054574 Plant ubiquitin promoter system |
| 04/25/2000 | US6054573 Highly infectious rubella virus clones and methods of production |
| 04/25/2000 | US6054572 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 04/25/2000 | US6054570 Selective expression of desired genes in cells expressing oncoproteins |
| 04/25/2000 | US6054569 Nucleotide and amino acid sequences from flavobacterium heparinum; for recombinant production of enyzmes for therapeutic agents |
| 04/25/2000 | US6054568 Polymer of nucleobases capable of watson/crick basepairing connected together by linkers and having terminating groups; for nucleic acid analogs which may be used in annealing, ligation, sequencing, cleavage and primer extension reactions |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054566 Recombinant animal viral nucleic acids |
| 04/25/2000 | US6054564 Cell line ak76 designated as atcc 55032; for automatic diagnosis of single base pair mutations |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054558 Amino acid sequence of isolated polypeptide from gene upregulated in endothelial cells in response to shear stress; for treatment and diagnosis of atherosclerosis, hypertension, ischemia/reperfusion, restenosis, and arterial inflammation |
| 04/25/2000 | US6054440 Antisense inhibition of Jun N-terminal Kinase Kinase-2 expression |
| 04/25/2000 | US6054439 Antisense olignucleotides having tumorigenicity-inhibiting activity |
| 04/25/2000 | US6054436 Regulated apoptosis |
| 04/25/2000 | US6054431 Anti-gram-positive bacterial methods and materials |
| 04/25/2000 | US6054327 Process for aligning macromolecules on a surface by passage through a meniscus |
| 04/25/2000 | US6054321 Forming three-dimensional structure of a fluorescent protein, constructing model of other fluorescent protein using first as template, making mutants by replacing amino acid(s) within 5 angstroms of any atom of chromophore |
| 04/25/2000 | US6054318 Genetic construct of nucleic acid segment from talaromyces flavus linked to promoter and to signal sequence; for plants with reduced susceptibility or increased pest/disease resistance |
| 04/25/2000 | US6054316 Compound 8 to 30 nucleobases in length targeted to 3' or 5'-untranslated regions or coding region of human transcription factor; for diagnosis or prophylaxis of cancer; anticarcinogenic agents |
| 04/25/2000 | US6054313 For diagnosis of persistant hyperinsulinemic hypoglycemia of infancy; for screening drugs and antidiabetic agents; for gene therapy |
| 04/25/2000 | US6054312 Receptor-mediated gene delivery using bacteriophage vectors |
| 04/25/2000 | US6054309 Ceramide glucosyltransferase |
| 04/25/2000 | US6054308 Arginase II |
| 04/25/2000 | US6054305 Pyruvate orthophosphate dikinase gene, recombinant DNA, and process for producing pyruvate orthophosphate dikinase |
| 04/25/2000 | US6054304 α1-6 fucosyltransferase |
| 04/25/2000 | US6054301 Methods of amplification using a thermostable DNA polymerase from the hyperthermophilic archaeon strain KOD1 and reagent kit therefor |
| 04/25/2000 | US6054299 Nucleotide sequences comprising replicon, inverted duplication, and restricion enzyme cleavage site |
| 04/25/2000 | US6054297 Preparing humanized immunoglobulin from complimentarity and human framework region; obtaining human and mammalian variable domain sequences, detecting, replacing, and adjusting sequences, detect binding, prepare immunoglobulin |
| 04/25/2000 | US6054296 66 kDa antigen from Borrelia |
| 04/25/2000 | US6054295 DNA molecules encoding human nuclear receptor proteins |
| 04/25/2000 | US6054293 Polypeptide involved in chemotatic response; screening for modulator proteins involved in nerve cell migration |
| 04/25/2000 | US6054292 T-cell receptor protein |
| 04/25/2000 | US6054291 Culturing cells to produce and recover human growth hormone |
| 04/25/2000 | US6054290 Human vesicle binding protein |
| 04/25/2000 | US6054289 Polynucleotides encoding human ADA2 |
| 04/25/2000 | US6054288 Drug delivery to mammalian cells; obtaining cells from a mammal, transfecting cells with vector epressing therapy agent, culturing transfected cells, introducing transfected cells into a mammal |
| 04/25/2000 | US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 04/25/2000 | US6054279 Detection of nucleic acids by fluorescence quenching |
| 04/25/2000 | US6054276 DNA restriction site mapping |
| 04/25/2000 | US6054275 Detection methods for cryptosporidium |
| 04/25/2000 | US6054267 Isolating deoxyribonucleic acid sequences containing at least a partial coding region for an enzyme in a sample; preferential detection and recovery of target nucleic acid by probes, transforming cells and producing expression library |
| 04/25/2000 | US6054265 Screening assays for compounds that inhibit membrane fusion-associated events |
| 04/25/2000 | US6054264 Methods of typing hepatitis C virus and reagents for use therein |
| 04/25/2000 | US6054163 Used as a food preservative |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054131 Vaccine composition for herpes simplex virus and method of using |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | US6054126 A synthetic polypeptide containing the conformational epitope recognized by monoclonal antibody mab 17-82 for neutralizing antibodies in an avian host; stimulating an immune response against infectious bursal disease virus in poultry |
| 04/25/2000 | US6054035 DNA sample preparation and electrophoresis analysis apparatus |
| 04/25/2000 | US6053088 Apparatus for use with non-lethal, electrical discharge weapons |
| 04/25/2000 | CA2169283C Method of nucleic acid sequence selection |
| 04/25/2000 | CA2155728C Regulated transcription of targeted genes and other biological events |
| 04/25/2000 | CA2098021C Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 04/25/2000 | CA2042808C Method of extracting particular nucleic acid fragment |
| 04/25/2000 | CA2019803C Feline interferon and process for production thereof |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/25/2000 | CA1340976C Fibroblast growth factor antagonists |
| 04/25/2000 | CA1340974C Plant universal stress-inducible regulatory element |
| 04/25/2000 | CA1340972C Follistatin and method of purifying same |
| 04/25/2000 | CA1340970C Lipase from gastric mucosa |
| 04/22/2000 | CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae |
| 04/20/2000 | WO2000022439A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 04/20/2000 | WO2000022435A1 Microarray system and process for performing biochemical reactions |
| 04/20/2000 | WO2000022430A2 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | WO2000022170A1 Metabolic selection methods |
| 04/20/2000 | WO2000022167A1 Method for determining transcription factor activity and its technical uses |
| 04/20/2000 | WO2000022166A2 Genes for assessing cardiovascular status and compositions for use thereof |
| 04/20/2000 | WO2000022165A1 Improved hybridisation assay in which excess probe is destroyed |
| 04/20/2000 | WO2000022164A1 Fluorescent probes for chromosomal painting |
| 04/20/2000 | WO2000022152A1 Compositions and methods for producing recombinant adeno-associated virus |
| 04/20/2000 | WO2000022151A1 Parvovirus vectors and their use |
| 04/20/2000 | WO2000022150A2 Limonene and other metabolites of geranyl pyrophosphate for insect control |
| 04/20/2000 | WO2000022149A1 Transformation process |
| 04/20/2000 | WO2000022148A1 METHOD FOR OBTAINING TRANSGENIC PLANTS EXPRESSING A PROTEIN WITH ACTIVITY PRODUCING HYDROGEN PEROXIDE BY TRANSFORMATION BY $i(AGROBACTERIUM RHIZOGENES) |
| 04/20/2000 | WO2000022147A1 Improved method for more efficient electroporation |
| 04/20/2000 | WO2000022146A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 04/20/2000 | WO2000022145A2 A hydroperoxide lyase gene from maize and methods of use |
| 04/20/2000 | WO2000022144A2 Means and methods for modulating stomata characteristica in plants |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022141A2 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 04/20/2000 | WO2000022140A1 NUCLEIC ACID MOLECULES WHICH CODE A BRANCHING ENZYME FROM BACTERIA OF THE GENUS NEISSERIA, AND A METHOD FOR PRODUCING α-1,6-BRANCHED α-1,4-GLUCANS |
| 04/20/2000 | WO2000022139A2 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds |